» Articles » PMID: 11408619

Loss of Huntingtin-mediated BDNF Gene Transcription in Huntington's Disease

Overview
Journal Science
Specialty Science
Date 2001 Jun 16
PMID 11408619
Citations 508
Authors
Affiliations
Soon will be listed here.
Abstract

Huntingtin is a 350-kilodalton protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder. The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain. However, loss of a beneficial activity of wild-type huntingtin may also cause the death of striatal neurons. Here we demonstrate that wild-type huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain. We show that this beneficial activity of huntingtin is lost when the protein becomes mutated, resulting in decreased production of cortical BDNF. This leads to insufficient neurotrophic support for striatal neurons, which then die. Restoring wild-type huntingtin activity and increasing BDNF production may be therapeutic approaches for treating HD.

Citing Articles

Advances in Huntington's Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review.

Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani A, Mohamed W Biology (Basel). 2025; 14(2).

PMID: 40001897 PMC: 11852324. DOI: 10.3390/biology14020129.


Human striatal progenitor cells that contain inducible safeguards and overexpress BDNF rescue Huntington's disease phenotypes.

Simmons D, Selvaraj S, Chen T, Cao G, Camelo T, McHugh T Mol Ther Methods Clin Dev. 2025; 33(1):101415.

PMID: 39995448 PMC: 11848452. DOI: 10.1016/j.omtm.2025.101415.


AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.

Choquet D, Opazo P, Zhang H Transl Neurodegener. 2025; 14(1):8.

PMID: 39934896 PMC: 11817889. DOI: 10.1186/s40035-025-00470-z.


CNPY2 protects against ER stress and is expressed by corticostriatal neurons together with CTIP2 in a mouse model of Huntington's disease.

Scordino M, Stepanova P, Srinivasan V, Pham D, Eriksson O, Lalowski M Front Mol Neurosci. 2024; 17:1473058.

PMID: 39359687 PMC: 11446244. DOI: 10.3389/fnmol.2024.1473058.


Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease.

Nateghi B, Keraudren R, Boulay G, Bazin M, Goupil C, Canet G Front Neurosci. 2024; 18:1421680.

PMID: 39170678 PMC: 11337869. DOI: 10.3389/fnins.2024.1421680.